Codexis Company Profile (NASDAQ:CDXS)

About Codexis (NASDAQ:CDXS)

Codexis logoCodexis, Inc. is a developer of biocatalysts for the pharmaceutical and fine chemicals markets. The Company's CodeEvolver protein engineering technology platform, which introduces genetic mutations into genes in order to give rise to changes in the enzymes that they produce, overcomes many of the limitations, allowing customers to evolve and optimize biocatalysts to perform specific and desired chemical reactions at commercial scale. The Company's pharmaceutical products include enzymes, pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and Codex Biocatalyst Panels and Kits. The fine chemicals market consists of several market verticals, including food and food ingredients, animal feed, flavors and fragrances, and agricultural chemicals. The Company also uses its technology to develop an early stage, enzyme therapeutic product candidate for the treatment of phenylketonuria (PKU) in humans through oral administration.

Industry, Sector and Symbol:
  • Sector: Industrial Products
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: Biotechnology
  • Symbol: NASDAQ:CDXS
  • CUSIP: 19200510
  • Web:
  • Market Cap: $352.77 million
  • Outstanding Shares: 48,324,000
Average Prices:
  • 50 Day Moving Avg: $6.41
  • 200 Day Moving Avg: $5.29
  • 52 Week Range: $3.60 - $7.95
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -40.56
  • P/E Growth: -1.13
Sales & Book Value:
  • Annual Revenue: $43.16 million
  • Price / Sales: 8.17
  • Book Value: $0.63 per share
  • Price / Book: 11.59
  • EBITDA: ($15,160,000.00)
  • Net Margins: -40.70%
  • Return on Equity: -83.39%
  • Return on Assets: -45.44%
  • Current Ratio: 3.06%
  • Quick Ratio: 2.99%
  • Average Volume: 170,002 shs.
  • Beta: -1.43
  • Short Ratio: 14.32

Frequently Asked Questions for Codexis (NASDAQ:CDXS)

What is Codexis' stock symbol?

Codexis trades on the NASDAQ under the ticker symbol "CDXS."

How were Codexis' earnings last quarter?

Codexis, Inc. (NASDAQ:CDXS) posted its quarterly earnings results on Wednesday, August, 9th. The company reported ($0.13) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.13). The company had revenue of $10.30 million for the quarter, compared to analyst estimates of $9.61 million. Codexis had a negative net margin of 40.70% and a negative return on equity of 83.39%. The company's quarterly revenue was down 35.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.12 earnings per share. View Codexis' Earnings History.

When will Codexis make its next earnings announcement?

Codexis is scheduled to release their next quarterly earnings announcement on Monday, November, 6th 2017. View Earnings Estimates for Codexis.

Where is Codexis' stock going? Where will Codexis' stock price be in 2017?

4 brokerages have issued 1-year target prices for Codexis' stock. Their predictions range from $5.50 to $11.00. On average, they anticipate Codexis' stock price to reach $7.81 in the next twelve months. View Analyst Ratings for Codexis.

Who are some of Codexis' key competitors?

Who are Codexis' key executives?

Codexis' management team includes the folowing people:

  • Bernard J. Kelley, Chairman of the Board
  • John J. Nicols, President, Chief Executive Officer, Director
  • Gordon T. Sangster, Chief Financial Officer, Senior Vice President
  • Douglas T. Sheehy J.D., Executive Vice President, Chief Administrative Officer, General Counsel, Secretary
  • Michael Douglas Arthur Aldridge, Senior Vice President - Corporate & Strategic Development
  • James Lalonde, Senior Vice President, Research & Development
  • Thomas R. Baruch J.D., Chairman Emeritus
  • Pam P. Cheng, Director
  • Kathleen Sereda Glaub, Director
  • Patrick Y. Yang, Director

Who owns Codexis stock?

Codexis' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include VIVO VENTURES VII, LLC (6.30%). Company insiders that own Codexis stock include Bernard J Kelley, Dennis P Wolf, James Lalonde, Patrick Y Yang, Ventures Fund Vii LP Vivo, Ventures Vii Affiliates F Vivo and Vivo Ventures Vii, Llc. View Institutional Ownership Trends for Codexis.

How do I buy Codexis stock?

Shares of Codexis can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Codexis' stock price today?

One share of Codexis stock can currently be purchased for approximately $7.30.

MarketBeat Community Rating for Codexis (NASDAQ CDXS)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  114 (Vote Outperform)
Underperform Votes:  130 (Vote Underperform)
Total Votes:  244
MarketBeat's community ratings are surveys of what our community members think about Codexis and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Codexis (NASDAQ:CDXS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $7.81 (7.02% upside)
Consensus Price Target History for Codexis (NASDAQ:CDXS)
Price Target History for Codexis (NASDAQ:CDXS)
Analysts' Ratings History for Codexis (NASDAQ:CDXS)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/13/2017Jefferies Group LLCBoost Price TargetBuy$9.00 -> $11.00N/AView Rating Details
10/13/2017HC WainwrightBoost Price TargetBuy -> Buy$8.00 -> $8.50N/AView Rating Details
1/26/2017First AnalysisDowngradeOverweight -> Equal Weight$5.50N/AView Rating Details
1/4/2017Ladenburg Thalmann Financial ServicesUpgradeNeutral -> Buy$6.25N/AView Rating Details
(Data available from 10/22/2015 forward)


Earnings History for Codexis (NASDAQ:CDXS)
Earnings by Quarter for Codexis (NASDAQ:CDXS)
Earnings History by Quarter for Codexis (NASDAQ CDXS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017($0.17)N/AView Earnings Details
8/9/2017Q2 2017($0.13)($0.13)$9.61 million$10.30 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.15)($0.18)$9.23 million$7.97 millionViewListenView Earnings Details
3/9/2017Q4 2016($0.11)($0.12)$9.15 million$10.00 millionViewListenView Earnings Details
11/8/2016Q3($0.14)$0.06$7.41 million$14.90 millionViewListenView Earnings Details
8/9/2016Q216$0.03$0.12$15.10 million$16.00 millionViewListenView Earnings Details
5/9/2016Q1($0.15)($0.11)$7.49 million$8.00 millionViewListenView Earnings Details
3/3/2016Q4($0.04)$0.02$11.63 million$11.60 millionViewN/AView Earnings Details
11/4/2015Q315($0.11)$0.13$8.85 million$17.40 millionViewListenView Earnings Details
8/11/2015Q215($0.14)($0.14)$7.34 million$6.02 millionViewListenView Earnings Details
5/7/2015Q115($0.12)($0.14)$8.00 million$6.80 millionViewListenView Earnings Details
3/3/2015Q414$0.01$0.07$13.30 million$14.20 millionViewListenView Earnings Details
11/4/2014Q314($0.06)($0.05)$9.00 million$7.47 millionViewListenView Earnings Details
8/6/2014Q214($0.15)($0.22)$8.50 million$6.60 millionViewListenView Earnings Details
5/7/2014Q114($0.10)($0.17)$10.00 million$7.10 millionViewListenView Earnings Details
3/11/2014Q413($0.21)($0.26)$10.00 million$9.50 millionViewListenView Earnings Details
11/12/2013Q313($0.31)($0.24)$8.50 million$3.90 millionViewListenView Earnings Details
8/9/2013Q2 2013($0.28)($0.33)$9.00 million$6.97 millionViewListenView Earnings Details
5/7/2013Q1 2013($0.36)($0.25)$7.63 million$11.48 millionViewListenView Earnings Details
2/27/2013Q4 2012($0.34)($0.41)$9.33 million$7.90 millionViewListenView Earnings Details
11/7/2012Q312($0.15)($0.06)$25.88 million$26.34 millionViewN/AView Earnings Details
8/9/2012($0.18)($0.15)ViewN/AView Earnings Details
5/10/2012($0.15)($0.21)ViewN/AView Earnings Details
2/7/2012($0.11)($0.15)ViewN/AView Earnings Details
11/1/2011($0.08)($0.08)ViewN/AView Earnings Details
7/28/2011($0.10)($0.14)ViewN/AView Earnings Details
5/5/2011($0.07)($0.10)ViewN/AView Earnings Details
2/3/2011($0.06)($0.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Codexis (NASDAQ:CDXS)
2017 EPS Consensus Estimate: ($0.35)
2018 EPS Consensus Estimate: ($0.13)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.10)($0.10)($0.10)
Q2 20172($0.14)($0.12)($0.13)
Q3 20172($0.17)($0.14)($0.16)
Q4 20171$0.04$0.04$0.04
Q1 20181($0.13)($0.13)($0.13)
Q2 20181($0.13)($0.13)($0.13)
Q3 20181($0.07)($0.07)($0.07)
Q4 20181$0.20$0.20$0.20
(Data provided by Zacks Investment Research)


Dividend History for Codexis (NASDAQ:CDXS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Codexis (NASDAQ:CDXS)
Insider Ownership Percentage: 9.80%
Institutional Ownership Percentage: 63.62%
Insider Trades by Quarter for Codexis (NASDAQ:CDXS)
Institutional Ownership by Quarter for Codexis (NASDAQ:CDXS)
Insider Trades by Quarter for Codexis (NASDAQ:CDXS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/14/2017Ventures Vii Affiliates F VivoMajor ShareholderSell1,060,000$5.78$6,126,800.00View SEC Filing  
11/15/2016Patrick Y YangDirectorBuy10,000$4.83$48,300.00View SEC Filing  
9/8/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell111,600$4.25$474,300.00View SEC Filing  
8/29/2016Dennis P WolfDirectorSell18,000$4.22$75,960.00View SEC Filing  
8/24/2016Bernard J KelleyDirectorSell12,643$4.26$53,859.18View SEC Filing  
8/16/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell86,894$4.25$369,299.50View SEC Filing  
8/15/2016Vivo Ventures Vii, LlcMajor ShareholderSell50,000$4.27$213,500.00View SEC Filing  
8/4/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell80,000$4.22$337,600.00View SEC Filing  
11/11/2015James LalondeSVPSell9,441$3.52$33,232.32View SEC Filing  
9/11/2015Patrick Y YangDirectorBuy10,000$3.47$34,700.00View SEC Filing  
9/10/2015Bernard J. KelleyDirectorSell5,200$3.45$17,940.00View SEC Filing  
8/24/2015Patrick Y YangDirectorBuy10,000$3.84$38,400.00View SEC Filing  
8/14/2015Patrick Y YangDirectorBuy20,000$3.97$79,400.00View SEC Filing  
6/15/2015Dennis P WolfDirectorSell35,416$4.10$145,205.60View SEC Filing  
11/18/2014Patrick Y YangDirectorBuy20,000$2.35$47,000.00View SEC Filing  
11/17/2014Patrick Y YangDirectorBuy20,000$2.34$46,800.00View SEC Filing  
8/12/2014Patrick Y YangDirectorBuy60,000$2.22$133,200.00View SEC Filing  
3/8/2013John J NicolsCEOBuy27,000$2.42$65,340.00View SEC Filing  
3/7/2013John J NicolsCEOBuy54,000$2.22$119,880.00View SEC Filing  
3/4/2013David D O'tooleCFOBuy10,000$2.02$20,200.00View SEC Filing  
11/12/2012David D O'tooleCFOBuy5,000$2.20$11,000.00View SEC Filing  
9/14/2012David D O'tooleCFOBuy5,000$2.78$13,900.00View SEC Filing  
9/14/2012Douglas T SheehySVPSell3,800$2.76$10,488.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Codexis (NASDAQ:CDXS)
Latest Headlines for Codexis (NASDAQ:CDXS)
Loading headlines, please wait.



Codexis (CDXS) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.